Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2016, Article ID 1651570, 7 pages
http://dx.doi.org/10.1155/2016/1651570
Review Article

Modern Treatments and Stem Cell Therapies for Perianal Crohn’s Fistulas

1St Paul’s Hospital, Vancouver BC, Canada
2University of British Columbia, Vancouver BC, Canada

Received 29 February 2016; Accepted 3 November 2016

Academic Editor: Přemysl Berčík

Copyright © 2016 Alghalya Khalid Sulaiman Al-Maawali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. A. Molodecky, I. S. Soon, D. M. Rabi et al., “Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review,” Gastroenterology, vol. 142, no. 1, pp. 46–e42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. E. V. Loftus Jr., “Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences,” Gastroenterology, vol. 126, no. 6, pp. 1504–1517, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. G. B. Rankin, H. D. Watts, C. S. Melnyk, and M. L. Kelley Jr., “National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications,” Gastroenterology, vol. 77, no. 4, pp. 914–920, 1979. View at Google Scholar · View at Scopus
  4. A. G. Parks, P. H. Gordon, and J. D. Hardcastle, “A classification of fistula in ano,” British Journal of Surgery, vol. 63, no. 1, pp. 1–12, 1976. View at Publisher · View at Google Scholar · View at Scopus
  5. L. J. Brandt, L. H. Bernstein, S. J. Boley, and M. S. Frank, “Metronidazole therapy for perineal Crohn's disease: A Follow-Up Study,” Gastroenterology, vol. 83, no. 2, pp. 383–387, 1982. View at Google Scholar · View at Scopus
  6. C. Prantera, E. Berto, M. L. Scribano, and G. Falasco, “Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin,” Italian Journal of Gastroenterology and Hepatology, vol. 30, no. 6, pp. 602–606, 1998. View at Google Scholar · View at Scopus
  7. K. T. Thia, U. Mahadevan, B. G. Feagan et al., “Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double‐blind, placebo‐controlled pilot study,” Inflammatory Bowel Diseases, vol. 15, no. 1, pp. 17–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. C. Pearson, G. R. May, G. H. Fick, and L. R. Sutherland, “Azathioprine and 6-mercaptopurine in Crohn disease. A Meta-analysis,” Annals of Internal Medicine, vol. 123, no. 2, pp. 132–142, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. D. H. Present, P. Rutgeerts, S. Targan et al., “Infliximab for the treatment of fistulas in patients with Crohn's disease,” The New England Journal of Medicine, vol. 340, no. 18, pp. 1398–1405, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. B. E. Sands, F. H. Anderson, C. N. Bernstein et al., “Infliximab Maintenance Therapy for Fistulizing Crohn's Disease,” New England Journal of Medicine, vol. 350, no. 9, pp. 876–885, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. B. W. Behm and S. J. Bickston, “Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease,” Cochrane Database of Systematic Reviews, no. 1, article no. CD006893, 2008. View at Google Scholar · View at Scopus
  12. J.-F. Colombel, D. A. Schwartz, W. J. Sandborn et al., “Adalimumab for the treatment of fistulas in patients with Crohn's disease,” Gut, vol. 58, no. 7, pp. 940–948, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Hinojosa, F. Gomollón, S. García et al., “Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial,” Alimentary Pharmacology and Therapeutics, vol. 25, no. 4, pp. 409–418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Schreiber, I. C. Lawrance, O. Ø. Thomsen, S. B. Hanauer, R. Bloomfield, and W. J. Sandborn, “Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease—subgroup results from a placebo-controlled study,” Alimentary Pharmacology and Therapeutics, vol. 33, no. 2, pp. 185–193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. S. Nanda, A. S. Cheifetz, and A. C. Moss, “Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis,” The American Journal of Gastroenterology, vol. 108, no. 1, pp. 40–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J.-F. Colombel, E. V. Loftus Jr., W. J. Tremaine et al., “The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients,” Gastroenterology, vol. 126, no. 1, pp. 19–31, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. W. J. Sandborn, D. H. Present, K. L. Isaacs et al., “Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial,” Gastroenterology, vol. 125, no. 2, pp. 380–388, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Chung, D. Ko, C. Sun, M. J. Raval, C. J. Brown, and P. T. Phang, “Outcomes of anal fistula surgery in patients with inflammatory bowel disease,” American Journal of Surgery, vol. 199, no. 5, pp. 609–613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Thornton and M. J. Solomon, “Long-term indwelling seton for complex anal fistulas in Crohn's disease,” Diseases of the Colon and Rectum, vol. 48, no. 3, pp. 459–463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-L. Faucheron, O. Saint-Marc, L. Guibert, and R. Parc, “Long-term seton drainage for high anal fistulas in Crohn's disease—a sphincter-saving operation?” Diseases of the Colon and Rectum, vol. 39, no. 2, pp. 208–211, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. P. Sangwan, D. J. Schoetz Jr., J. J. Murray, P. L. Roberts, and J. A. Coller, “Perianal Crohn's disease. Results of local surgical treatment,” Diseases of the Colon and Rectum, vol. 39, no. 5, pp. 529–535, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. W. J. Sandborn, V. W. Fazio, B. G. Feagan, and S. B. Hanauer, “AGA technical review on perianal Crohn's disease,” Gastroenterology, vol. 125, no. 5, pp. 1508–1530, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Joo, E. G. Weiss, J. J. Nogueras, and S. D. Wexner, “Endorectal advancement flap in perianal Crohn's disease,” American Surgeon, vol. 64, no. 2, pp. 147–150, 1998. View at Google Scholar · View at Scopus
  24. T. Sonoda, T. Hull, M. R. Piedmonte, and V. W. Fazio, “Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap,” Diseases of the Colon and Rectum, vol. 45, no. 12, pp. 1622–1628, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. I. S. Bleier, H. Moloo, and S. M. Goldberg, “Ligation of the intersphincteric fistula tract: an effective new technique for complex fistulas,” Diseases of the Colon and Rectum, vol. 53, no. 1, pp. 43–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Shanwani, A. M. Nor, and M. K. Nil Amri, “Ligation of the intersphincteric fistula tract (LIFT): a sphincter-saving technique for fistula-in-ano,” Diseases of the Colon and Rectum, vol. 53, no. 1, pp. 39–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Ooi, I. Skinner, M. Croxford, I. Faragher, and S. McLaughlin, “Managing fistula-in-ano with ligation of the intersphincteric fistula tract procedure: the Western Hospital experience,” Colorectal Disease, vol. 14, no. 5, pp. 599–603, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. BMJ Best Practice, http://bestpractice.bmj.com/.
  29. American college of gastroenterology, http://gi.org/education-and-meetings/regional-meetings/2014-acg-board-of-governorsasge-best-practices-course-session-handouts.
  30. M. Regueiro and H. Mardini, “Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement,” Inflammatory Bowel Diseases, vol. 9, no. 2, pp. 98–103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. D. R. Topstad, R. Panaccione, J. A. Heine, D. R. E. Johnson, A. R. MacLean, and W. D. Buie, “Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience,” Diseases of the Colon and Rectum, vol. 46, no. 5, pp. 577–583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. L. S. Poritz, W. A. Rowe, and W. A. Koltun, “Remicade does not abolish the need for surgery in fistulizing Crohn's disease,” Diseases of the Colon & Rectum, vol. 45, no. 6, pp. 771–775, 2002. View at Google Scholar
  33. J.-C. Grimaud, N. Munoz-Bongrand, L. Siproudhis et al., “Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease,” Gastroenterology, vol. 138, no. 7, pp. 2275–2281.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Lindsey, M. M. Smilgin-Humphreys, C. Cunningham, N. J. M. Mortensen, and B. D. George, “A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula,” Diseases of the Colon and Rectum, vol. 45, no. 12, pp. 1608–1615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. O'Riordan, I. Datta, C. Johnston, and N. N. Baxter, “A systematic review of the anal fistula plug for patients with Crohn's and non-Crohn's related fistula-in-ano,” Diseases of the Colon and Rectum, vol. 55, no. 3, pp. 351–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Ruzicka, T. Bieber, E. Schöpf et al., “A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group,” The New England Journal of Medicine, vol. 337, no. 12, pp. 816–821, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. K. McSharry, A. M. Dalzell, K. Leiper, and W. El-Matary, “Systematic review: the role of tacrolimus in the management of Crohn's disease,” Alimentary Pharmacology and Therapeutics, vol. 34, no. 11-12, pp. 1282–1294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. L. Hart, S. Plamondon, and M. A. Kamm, “Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial,” Inflammatory Bowel Diseases, vol. 13, no. 3, pp. 245–253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Poggioli, S. Laureti, F. Pierangeli et al., “Local injection of infliximab for the treatment of perianal Crohn's disease,” Diseases of the Colon and Rectum, vol. 48, no. 4, pp. 768–774, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. C. R. Asteria, F. Ficari, S. Bagnoli, M. Milla, and F. Tonelli, “Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-α accounts for a favourable clinical response in selected cases: A Pilot Study,” Scandinavian Journal of Gastroenterology, vol. 41, no. 9, pp. 1064–1072, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Alessandroni, A. Kohn, R. Cosintino et al., “Local injection of infliximab in severe fistulating perianal Crohn's disease: an open uncontrolled study,” Techniques in Coloproctology, vol. 15, no. 4, pp. 407–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. P. E. Drakos, A. Nagler, and R. Or, “Case of Crohn's disease in bone marrow transplantation,” American Journal of Hematology, vol. 43, no. 2, pp. 157–158, 1993. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Kashyap and S. J. Forman, “Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease,” British Journal of Haematology, vol. 103, no. 3, pp. 651–652, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. R. K. Burt, S. Slavin, W. H. Burns, and A. M. Marmont, “Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?” International journal of hematology, vol. 76, supplement 1, pp. 226–247, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. E. A. Copelan, “Hematopoietic stem-cell transplantation,” The New England Journal of Medicine, vol. 354, no. 17, pp. 1813–1826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. O. García-Bosch, E. Ricart, and J. Panés, “Review article: stem cell therapies for inflammatory bowel disease—efficacy and safety,” Alimentary Pharmacology and Therapeutics, vol. 32, no. 8, pp. 939–952, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. R. K. Burt, R. M. Craig, F. Milanetti et al., “Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up,” Blood, vol. 116, no. 26, pp. 6123–6132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Cassinotti, F. Onida, C. Annaloro et al., “Autologous haematopoietic stem cell transplantation without CD34+ cell selection for refractory Crohn's disease: the Milan experience after 5 years,” Journal of Crohn's and Colitis, vol. 6, pp. 153–154, 2012. View at Google Scholar
  49. W. K. van Deen, A. Oikonomopoulos, and D. W. Hommes, “Stem cell therapy in inflammatory bowel disease: which, when and how?” Current Opinion in Gastroenterology, vol. 29, no. 4, pp. 384–390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. A. Snowden, R. Saccardi, M. Allez et al., “Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European group for blood and marrow transplantation,” Bone Marrow Transplantation, vol. 47, no. 6, pp. 770–790, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. A. J. Friedenstein, R. K. Chailakhjan, and K. S. Lalykina, “The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells,” Cell and Tissue Kinetics, vol. 3, no. 4, pp. 393–403, 1970. View at Google Scholar · View at Scopus
  52. A. I. Caplan, “Mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641–650, 1991. View at Publisher · View at Google Scholar · View at Scopus
  53. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., “Multilineage potential of adult human mesenchymal stem cells,” Science, vol. 284, no. 5411, pp. 143–147, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. I. García-Gómez, G. Elvira, A. G. Zapata et al., “Mesenchymal stem cells: biological properties and clinical applications,” Expert Opinion on Biological Therapy, vol. 10, no. 10, pp. 1453–1468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. M. A. González, E. Gonzalez-Rey, L. Rico, D. Büscher, and M. Delgado, “Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses,” Gastroenterology, vol. 136, no. 3, pp. 978–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. D. García-Olmo, M. García-Arranz, L. Gómez García et al., “Autologous stem cell transplantation for treatment of rectovaginal fistula in perinatal Crohn's disease: a new cell-based therapy,” International Journal of Colorectal Disease, vol. 18, no. 5, pp. 451–454, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Garcia-Olmo, M. Garcia-Arranz, and D. Herreros, “Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease,” Expert Opinion on Biological Therapy, vol. 8, no. 9, pp. 1417–1423, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Ciccocioppo, M. E. Bernardo, A. Sgarella et al., “Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease,” Gut, vol. 60, no. 6, pp. 788–798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. D. García-Olmo, M. García-Arranz, D. Herreros, I. Pascual, C. Peiro, and J. A. Rodríguez-Montes, “A phase I clinical trial of the treatment of crohn's fistula by adipose mesenchymal stem cell transplantation,” Diseases of the Colon and Rectum, vol. 48, no. 7, pp. 1416–1423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Garcia-Olmo, D. Herreros, I. Pascual et al., “Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial,” Diseases of the Colon and Rectum, vol. 52, no. 1, pp. 79–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M. D. Herreros, M. Garcia-Arranz, H. Guadalajara, P. De-La-Quintana, and D. Garcia-Olmo, “Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula advanced therapy trial 1) and long-term evaluation,” Diseases of the Colon and Rectum, vol. 55, no. 7, pp. 762–772, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Panés, D. Garcia-Olmo, G. Van Assche et al., “Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial,” The Lancet, vol. 388, no. 10051, pp. 1281–1290, 2016. View at Publisher · View at Google Scholar
  63. D. Garcia-Olmo and D. A. Schwartz, “Cumulative evidence that mesenchymal stem cells promote healing of perianal fistulas of patients with Crohn's disease—going from bench to bedside,” Gastroenterology, vol. 149, no. 4, Article ID 59998, pp. 853–857, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. I. Molendijk, B. A. Bonsing, H. Roelofs et al., “Allogeneic bone marrow–derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease,” Gastroenterology, vol. 149, no. 4, pp. 918–927, 2015. View at Publisher · View at Google Scholar · View at Scopus